7-BROMO-4,5-DIHYDRO-1H-BENZO[B]AZEPIN-2(3H)-ONE, 95%, 100mg

4-Cyanophenyl ether, 25g

tert-Butyl 6-fluoro-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole-1-carboxylate, 95.0%, 250mg

[1-(3,4-dimethoxyphenyl)propyl]amine, 95.0%, 5g

Systèmes de dialyse Spectra/Por® Float-A-Lyzer® G2 Volume de remplissage 10 ml, 300000 dalton(s), 12 pièce(s)

(R)-tert-Butyl 2-amino-3-(3-bromophenyl)propanoate, 95.0%, 10g

3-(2,2-Difluoroethoxy)pyridine-2-carboxylic acid, 95%, 250mg

2,4-Diamino-6-diallylamino-1,3,5-triazine>98.0%(HPLC)(T)25g

Trozos de galio 99,99% 50 g

4-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 97.0%, 250mg

Sal sódica de D-luciferina, mín. 99 %, para bioquímica, 25 mg, envase de vidrio

5-Nonanone>98.0%(GC)25mL

2-(Aminomethyl)-1H-benzo[d]imidazole-6-carboxylic acid dihydrochloride, 97%, 10g